Cargando…

A Comparison Between Sequential Conventional and Hypofractionated Boost Following Whole-Breast Radiotherapy: A Propensity Score-Matched Analysis

Background: The majority of local relapses after breast conservation therapy occur in the proximity of the primary lesion. Studies have shown that boost radiotherapy (RT) following conventional whole-breast radiotherapy (WBRT) of 50 Gy in five weeks improves outcomes. Boost RT also increases the ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajan, Jewel, KR, Rajeev, Sara George, Preethi, Arjunan, Asha, Balakrishnan, Priya, Augustine, Paul, Sarah Mathew, Beela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639086/ https://www.ncbi.nlm.nih.gov/pubmed/37954819 http://dx.doi.org/10.7759/cureus.46913

Ejemplares similares

Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
por: Youssef, Ashraf, et al.
Publicado: (2018)

Short Course Hypofractionated Radiotherapy for Frail or Elderly Patients With Meningioma
por: Sarhan, Nasim, et al.
Publicado: (2020)

Feasibility, Tolerance, and Quality of Life for Hypofractionation Versus Conventional Fractionation for Post-mastectomy Radiotherapy in Indian Patients
por: Malik, Deepika, et al.
Publicado: (2022)

Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
por: Zhou, Wei, et al.
Publicado: (2022)

Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis
por: Lee, Anbok, et al.
Publicado: (2022)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer
por: Jin, Xiance, et al.
Publicado: (2013)

Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
por: Yu, Edward, et al.
Publicado: (2015)

Dosimetric comparison of VitalBeam(®) and Halcyon(TM) 2.0 for hypofractionated VMAT with simultaneous integrated boost treatment of early‐stage left‐sided breast cancer
por: Ju, Eunbin, et al.
Publicado: (2021)

Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent Bevacizumab
por: Chaudhuri, Aadel A, et al.
Publicado: (2016)

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate
por: Gopaul, Darin, et al.
Publicado: (2018)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Salvage Hypofractionated Radiotherapy in a Progressive Radiation-Induced Angiosarcoma: A Case Report
por: Bonzano, Elisabetta, et al.
Publicado: (2017)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer
por: Piotrowski, Tomasz, et al.
Publicado: (2022)

Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer
por: Hughes, Ryan T, et al.
Publicado: (2019)

Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience
por: Sallabanda, Morena, et al.
Publicado: (2021)

Inter‐ and intrafractional dose uncertainty in hypofractionated Gamma Knife radiosurgery
por: Kim, Taeho, et al.
Publicado: (2016)

Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes
por: Staehler, Michael, et al.
Publicado: (2022)

Propensity score matching with R: conventional methods and new features
por: Zhao, Qin-Yu, et al.
Publicado: (2021)

Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis
por: Bauman, Glenn, et al.
Publicado: (2020)

Comparison of Moderate Hypofractionated Volumetric-Modulated Arc Therapy Plans With and Without Flattening Filter for Localized Prostate Cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2021)

A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery
por: Yu, Ting, et al.
Publicado: (2021)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Role of Hypofractionated Stereotactic Radiosurgery in Recurrent Pineal Parenchymal Tumors of Intermediate Differentiation: A Case Report and Review of the Literature
por: Beduk Esen, Caglayan Selenge, et al.
Publicado: (2020)

Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium
por: Dincer, Neris, et al.
Publicado: (2022)

Robot-assisted vs. conventional MIDCAB: A propensity-matched analysis
por: Gofus, Jan, et al.
Publicado: (2022)

Adaptive radiation therapy strategies in the treatment of prostate cancer patients using hypofractionated VMAT
por: Siciarz, Pawel, et al.
Publicado: (2021)

Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis
por: Zayed, Sondos, et al.
Publicado: (2020)

Magnetic field dose effects on different radiation beam geometries for hypofractionated partial breast irradiation
por: Kim, Anthony, et al.
Publicado: (2017)

Comparative effectiveness of simultaneous integrated boost vs sequential intensity-modulated radiotherapy for oropharyngeal or hypopharyngeal cancer patients: A population-based propensity score-matched analysis
por: Kuo, Yao-Hung, et al.
Publicado: (2019)

Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM
por: Jia, Angela, et al.
Publicado: (2016)

Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2022)

Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
por: Viani, Gustavo Arruda, et al.
Publicado: (2013)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Dose calculation for hypofractionated volumetric‐modulated arc therapy: approximating continuous arc delivery and tongue‐and‐groove modeling*
por: Yang, Jie, et al.
Publicado: (2016)

Dosimetric effects of positioning shifts using 6D‐frameless stereotactic Brainlab system in hypofractionated intracranial radiotherapy
por: Jin, Hosang, et al.
Publicado: (2016)

Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer
por: Li, Ming‐Hsien, et al.
Publicado: (2018)

Benchmarking halcyon ring delivery system for hypofractionated breast radiotherapy: Validation and clinical implementation of the fast‐forward trial
por: Pokhrel, Damodar, et al.
Publicado: (2023)

Quality of Life determinants in women with breast cancer undergoing treatment with curative intent
por: Pandey, Manoj, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_072ocb1hpsnan1pi40j33acdo7